Avid Bioservices Announces Appointment of Two Senior Directors of Business Development with Responsibility for North America, Europe and Asia
April 13, 2020 08:05 ET
|
Avid Bioservices, Inc
TUSTIN, Calif., April 13, 2020 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated biologics contract development and manufacturing organization (CDMO) working to...
Cytovance Biologics Promotes Dr. Jesse McCool to Chief Executive Officer
March 30, 2020 03:00 ET
|
Cytovance Biologics
OKLAHOMA CITY, March 30, 2020 (GLOBE NEWSWIRE) -- Cytovance® Biologics, a leading biopharmaceutical contract development and manufacturing organization (CDMO), announces the appointment of Dr. Jesse...
Avid Bioservices Receives Five 2020 CMO Leadership Awards
March 26, 2020 08:05 ET
|
Avid Bioservices, Inc
Company Honored for Capabilities, Expertise, Reliability, Compatibility, and Service in the Contract Development and Manufacturing Industry Named 2020 CMO Leadership Award Champion in Categories of...
Avid Bioservices Reports Financial Results for Third Quarter Fiscal 2020 and Recent Developments
March 10, 2020 16:05 ET
|
Avid Bioservices, Inc
-- Recorded Third Quarter Revenue of $13.6 Million -- -- Signed New Customer and Project Expansion Orders with Current Customers for $20 Million -- -- Adjusting Fiscal 2020 Projected Revenue to $55...
Avid Bioservices Declares Quarterly Dividend on Its Series E Convertible Preferred Stock
March 04, 2020 16:05 ET
|
Avid Bioservices, Inc
TUSTIN, Calif., March 04, 2020 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated biologics contract development and manufacturing organization (CDMO) working to...
Avid Bioservices to Report Financial Results for Third Quarter of Fiscal Year 2020 After Market Close on March 10, 2020
March 03, 2020 16:05 ET
|
Avid Bioservices, Inc
TUSTIN, Calif., March 03, 2020 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated biologics contract development and manufacturing organization (CDMO) working to...
Sterility Testing Market To Reach USD 1.18 Billion By 2026 | Reports and Data
February 25, 2020 14:00 ET
|
Reports and Data
New York, Feb. 25, 2020 (GLOBE NEWSWIRE) -- According to the current analysis of Reports and Data, the global Sterility Testing market was valued at USD 466.0 million in 2018 and is expected to...
Ankylosing Spondylitis Drugs Market To Reach USD 8.82 Billion By 2027 | Reports And Data
February 11, 2020 16:00 ET
|
Reports and Data
New York, Feb. 11, 2020 (GLOBE NEWSWIRE) -- The global ankylosing spondylitis drugs market is forecast to reach USD 8.82 Billion by 2027, according to a new report by Reports and Data. Ankylosing...
Amarantus Announces Subsidiary MANF Therapeutics Enters Into Material Transfer Agreement with Dyadic International
February 06, 2020 08:11 ET
|
Amarantus Bioscience Holdings, Inc.
New York, NY, Feb. 06, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Amarantus Bioscience Holdings, Inc. (OTC Pink: AMBS) (“Amarantus,” or AMBS), a biotechnology holding company pursuing proprietary...
Avid Bioservices Appoints Timothy Compton as Chief Commercial Officer
January 08, 2020 08:05 ET
|
Avid Bioservices, Inc
TUSTIN, Calif., Jan. 08, 2020 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated biologics contract development and manufacturing organization (CDMO) working to...